NECTIN1 and glioblastoma: Interestingly, almost no significant increases in natural killer (NK) cells were observed in both GBM models, and the frequency was even reduced at day 7 post-M002 treatment in the GL261-PVRL1 model (Supplementary Fig. 3c, d).